Jane A. Gross - Apr 26, 2023 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Director
Signature
/s/ Nancy E. Denyes, attorney-in-fact
Stock symbol
LIFE
Transactions as of
Apr 26, 2023
Transactions value $
$0
Form type
4
Date filed
4/28/2023, 04:52 PM
Previous filing
Aug 1, 2022
Next filing
May 19, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common stock Options Exercise +6K 6K Apr 26, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Restricted Stock Unit Options Exercise $0 -6K -100% $0.00* 0 Apr 26, 2023 Common Stock 6K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.
F2 RSUs convert into common stock on a one-for-one basis.
F3 The RSUs fully vested one year from the grant date which was April 26, 2022.